1M6MYTD1Y5YMAX
Loading quotes...
Forecast
The analysts' average price target is €86.31 (+14,049.18%). The median is €86.31 (+14,049.18%).
| Buy |
6 |
| Hold |
1 |
| Sell |
0 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | Jun 2026 | |
|---|---|---|
| Revenue | 0 | 100.00% |
| Gross profit | -10.58K | 99.68% |
| Net profit | -3.88M | 14.86% |
| EBITDA | -3.88M | 14.53% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €4.55M |
Number of shares | 7.37M |
52-week high/low | €16.57 - €0.51 |
| Dividends | No |
Beta | 3.66 |
P/E ratio | -0.05 |
PEG ratio | 0.00 |
P/B ratio | 1.85 |
P/S ratio | 0.00 |
Company profile
| Name | GeoVax Labs |
| CEO | David Alan Dodd |
| Employees | 19 |
Discover assets
Shareholders of GeoVax Labs also invest in the following assets
